Axe man cometth






















This is not happening. About to launch a novel dry eye medication. All hands on deck!
The current state of this company is neutral to MAHA. In other words, there is not a financial incentive to act unethically. That's critical. Finding a niche to fill in the MAHA report/plan will prove to be financially beneficial, and that's the reward.
 















Write your reply...